ORIC Pharmaceuticals (NASDAQ:ORIC) reported quarterly earnings results on February 23, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.30, beating the consensus estimate of $-0.36 by $0.06 per share. Revenue came in at , meeting the estimate of .
ORIC Pharmaceuticals's stock moved following the earnings release. The stock currently trades at $12.27 with a market capitalization of $944.7M.